|
|
Article: Roche targets diabetes care.(RX/Diabetes Care)(Roche Holding Ltd.)
- Article from:
- Chain Drug Review
- Article date:
- June 30, 2008
|
Copyright informationCOPYRIGHT 2008 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ZURICH -- Cancer drugs have propelled Roche Holding AG's profit by more than 20% a year since 2004, but the company is racing to break into the fast-expanding, $21 billion-a-year diabetes market. Switzerland's biggest drug manufacturer is challenging Novo Nordisk AS and Eli Lilly and Co., the world's biggest marketers of insulin, with drugs that may make daily diabetes injections a thing of the past.
Roche is reportedly testing several treatments to help it exploit the diabetes market before patents expire on its cancer medicines. And although the leading diabetes drug candidate is a year behind a similar one from Lilly, analysts assert that Roche's financial strength may ...
Related newspaper, magazine, and journal articles:
|
|
Article: Nursing home residents more susceptible to drug side effects.
McKnight's Long-Term Care News;
October 30, 2000 ;
700+ words
...Drug side effects -- such as dry mouth, difficulty urinating...community to be prescribed drugs with side effects that often are mistaken for the effects...residents are given drugs that produce side effects, compared with only 23% of elderly...
|
|